# Braeburn

**Source:** https://www.startuphub.ai/startups/braeburn
**Profile type:** Startup

> Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

## About

Braeburn Pharmaceuticals is focused on developing long-acting implantable and injectable therapies for opioid addiction and chronic pain. Their lead product, Probufine (buprenorphine implant), is FDA-approved for opioid dependence, and another product, CAM2038, is in the NDA refilling process for opioid dependence and in Phase 3 for pain management. The company aims to transform the management of opioid use disorder by eliminating stigma and improving access to treatment.

## Key facts

- **Slug:** braeburn
- **Website:** https://www.braeburnrx.com/
- **Location:** Plymouth Meeting, PA, United States
- **Founded:** 2012-01-01
- **Employees:** 276
- **Operating status:** Active
- **Total funding:** $133M
- **Sectors / tags:** Biotech, HealthTech, Drug Discovery, Biotechnology, Life Sciences, Pharmaceuticals, Addiction Treatment
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/braeburn
  - Twitter: https://twitter.com/braeburnrx

## Frequently asked

### What does Braeburn do?

Braeburn Pharmaceuticals is focused on developing long-acting implantable and injectable therapies for opioid addiction and chronic pain. Their lead product, Probufine (buprenorphine implant), is FDA-approved for opioid dependence, and another product, CAM2038, is in the NDA refilling process for opioid dependence and in Phase 3 for pain management. The company aims to transform the management of opioid use disorder by eliminating stigma and improving access to treatment.

### What is Braeburn's revenue?

StartupHub estimates Braeburn's annual revenue at $59.7M (range $32.8M to $137.6M, 65% confidence), based on comparable companies in the sector.

### What is Braeburn's valuation?

StartupHub estimates Braeburn's effective valuation at $478.8M (range $332.5M to $798.0M, 10% confidence), based on comparable companies in the sector.

### How much funding has Braeburn raised?

Braeburn has raised a total of $133M in funding. The most recent round on record is Conventional Debt.

### Where is Braeburn headquartered?

Braeburn is headquartered in Plymouth Meeting, PA, United States.

### When was Braeburn founded?

Braeburn was founded in 2012.

### What industry does Braeburn operate in?

Braeburn operates in Biotech, HealthTech, Drug Discovery, Biotechnology, Life Sciences, Pharmaceuticals.

### How many employees does Braeburn have?

Braeburn has approximately 276 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "Braeburn",
          "item": "https://www.startuphub.ai/startups/braeburn"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/braeburn#webpage",
      "url": "https://www.startuphub.ai/startups/braeburn",
      "name": "Braeburn - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of Braeburn. Braeburn is a startup founded in 2012, operating in Biotech and HealthTech. Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain. Headquartered in Plymouth Meeting, PA, United States. The company has approximately 276 employees.",
      "dateModified": "2026-08-01T09:44:42.52+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/braeburn#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/braeburn#organization",
      "name": "Braeburn",
      "url": "https://www.braeburnrx.com/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/dfee3695-7980-409f-a383-ebc120c5ca9f-square.webp",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/dfee3695-7980-409f-a383-ebc120c5ca9f-square.webp",
      "description": "This is the official profile of Braeburn. Braeburn is a startup founded in 2012, operating in Biotech and HealthTech. Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain. Headquartered in Plymouth Meeting, PA, United States. The company has approximately 276 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/braeburn",
        "https://twitter.com/braeburnrx",
        "https://www.startuphub.ai/startups/braeburn"
      ],
      "foundingDate": "2012-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 276
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Plymouth Meeting",
        "addressRegion": "PA",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotech",
        "HealthTech",
        "Drug Discovery",
        "Biotechnology",
        "Life Sciences",
        "Pharmaceuticals",
        "Addiction Treatment"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/braeburn#profile-assessment",
      "name": "Braeburn - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/braeburn",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/logos/dfee3695-7980-409f-a383-ebc120c5ca9f-square.webp",
      "category": "Biotech",
      "description": "This is the official profile of Braeburn. Braeburn is a startup founded in 2012, operating in Biotech and HealthTech. Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain. Headquartered in Plymouth Meeting, PA, United States. The company has approximately 276 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/braeburn/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "Braeburn"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-08-01",
        "name": "Braeburn - Profile Score 50/100",
        "reviewBody": "This is the official profile of Braeburn. Braeburn is a startup founded in 2012, operating in Biotech and HealthTech. Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain. Headquartered in Plymouth Meeting, PA, United States. The company has approximately 276 employees. Agent Readiness score: 32/100. Full audit: https://www.startuphub.ai/startups/braeburn/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 50,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```
